TY - JOUR
T1 - Acute caffeine supplementation offsets the impairment in 10-km running performance following one night of partial sleep deprivation
T2 - a randomized controlled crossover trial
AU - Tsai, Yi Shan
AU - Chen, Ting Tzu
AU - Chan, Yau Ching
AU - Huang, Chun Chin
AU - Lai, Ting Fu
AU - Liao, Yung
AU - Metcalfe, Richard S.
AU - Chen, Yung Chih
AU - Wang, Ho Seng
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024.
PY - 2025/3
Y1 - 2025/3
N2 - Introduction: Whether acute caffeine supplementation can offset the negative effects of one-night of partial sleep deprivation (PSD) on endurance exercise performance is currently unknown. Methods: Ten healthy recreational male runners (age: 27 ± 6 years; V˙O2max: 61 ± 9 mL/kg/min) completed 4 trials in a balanced Latin square design, which were PSD + caffeine (PSD-Caf), PSD + placebo (PSD-Pla), normal sleep (NS) + caffeine (NS-Caf) and NS + placebo (NS-Pla). 3 and 8 h sleep windows were scheduled in PSD and NS, respectively. 10-km treadmill time trial (TT) performance was assessed 45 min after caffeine (6 mg/kg/body mass)/placebo supplementation in the morning following PSD/NS. Blood glucose, lactate, free fatty acid and glycerol were measured at pre-supplementation, pre-exercise and after exercise. Results: PSD resulted in compromised TT performance compared to NS in the placebo conditions by 5% (51.9 ± 7.7 vs. 49.4 ± 6.9 min, p = 0.001). Caffeine improved TT performance compared to placebo following both PSD by 7.7% (PSD-Caf: 47.9 ± 7.3 min vs. PSD-Pla: 51.9 ± 7.7 min, p = 0.007) and NS by 2.8% (NS-Caf: 48.0 ± 6.4 min vs. NS-Pla: 49.4 ± 6.9 min, p = 0.049). TT performance following PSD-Caf was not different from either NS-Pla or NS-Caf (p = 0.185 and p = 0.891, respectively). Blood glucose, lactate, and glycerol concentrations at post-exercise, as well as heart rate and the speed/RPE ratio during TT, were higher in caffeine trials compared to placebo. Conclusions: Caffeine supplementation offsets the negative effects of one-night PSD on 10-km running performance.
AB - Introduction: Whether acute caffeine supplementation can offset the negative effects of one-night of partial sleep deprivation (PSD) on endurance exercise performance is currently unknown. Methods: Ten healthy recreational male runners (age: 27 ± 6 years; V˙O2max: 61 ± 9 mL/kg/min) completed 4 trials in a balanced Latin square design, which were PSD + caffeine (PSD-Caf), PSD + placebo (PSD-Pla), normal sleep (NS) + caffeine (NS-Caf) and NS + placebo (NS-Pla). 3 and 8 h sleep windows were scheduled in PSD and NS, respectively. 10-km treadmill time trial (TT) performance was assessed 45 min after caffeine (6 mg/kg/body mass)/placebo supplementation in the morning following PSD/NS. Blood glucose, lactate, free fatty acid and glycerol were measured at pre-supplementation, pre-exercise and after exercise. Results: PSD resulted in compromised TT performance compared to NS in the placebo conditions by 5% (51.9 ± 7.7 vs. 49.4 ± 6.9 min, p = 0.001). Caffeine improved TT performance compared to placebo following both PSD by 7.7% (PSD-Caf: 47.9 ± 7.3 min vs. PSD-Pla: 51.9 ± 7.7 min, p = 0.007) and NS by 2.8% (NS-Caf: 48.0 ± 6.4 min vs. NS-Pla: 49.4 ± 6.9 min, p = 0.049). TT performance following PSD-Caf was not different from either NS-Pla or NS-Caf (p = 0.185 and p = 0.891, respectively). Blood glucose, lactate, and glycerol concentrations at post-exercise, as well as heart rate and the speed/RPE ratio during TT, were higher in caffeine trials compared to placebo. Conclusions: Caffeine supplementation offsets the negative effects of one-night PSD on 10-km running performance.
KW - Endurance performance
KW - Marathon
KW - Sleep deprivation
KW - Sports nutrition
KW - Supplements
UR - http://www.scopus.com/inward/record.url?scp=86000432146&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=86000432146&partnerID=8YFLogxK
U2 - 10.1007/s00421-024-05638-5
DO - 10.1007/s00421-024-05638-5
M3 - Article
C2 - 39438312
AN - SCOPUS:86000432146
SN - 1439-6319
VL - 125
SP - 825
EP - 835
JO - European Journal of Applied Physiology
JF - European Journal of Applied Physiology
IS - 3
M1 - e13857
ER -